Indeed, none of the five genes identified in the TCGA analysis as ACC-associated—TP53, CTNNB1, ATRX, MEN1, and PRKAR1A—can be argued to be truly “druggable”. This evidence concerns the gene TP53 and adrenal cortex carcinoma.